Blog

Leading the Way in Effective Drug Development

Adobe Stock 171183913
Oct 03, 2023

Neuropathic Pain Trials Combine Drug Adherence, E-Diaries for Personalized Interventions

The percentage of people in pain around the world rose from 26.3% in 2009 to 32.1% in 2021, an increase of approximately 500 million people. Persistent pain in the U.S. is estimated to affect over 100 million adults at any given time, and carries direct and indirect costs of over $600 billion annually.

Adobe Stock 546489931 resize
Aug 23, 2023

Psoriasis Clinical Trials Aim to Improve Disease Management, Drug Adherence

Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting course, which affects 2–3% of the worldwide population. This blog provides a brief overview of medication adherence in psoriasis, a snapshot of the psoriasis clinical trial landscape, and a look at technology used to improve dosing performance in psoriasis clinical research.

Adobe Stock 6056560 edited resize
Aug 09, 2023

Clinical Trials in Chronic Hepatitis B Look To Optimize Dose, Regimen For Tolerable Immune Activation

Chronic hepatitis B virus (HBV) infection affects about 296 million people globally and is the leading worldwide cause of cirrhosis and liver cancer.

Adobe Stock 321996582 resize
Jul 25, 2023

The Future of Anti-Obesity Medications: Clinical Trials and Adherence Challenges

The prevalence of obesity has been steadily increasing worldwide, leading to a growing demand for effective anti-obesity medications. In recent years, clinical trials have focused on developing new drugs with better efficacy and safety profiles.

Adobe Stock 391064613 resize
Apr 14, 2023

Medication Adherence Tech and Predictive Analytics Support Patient Retention in Schizophrenia Clinical Trials

The rising prevalence of Central Nervous System (CNS) disorders due to a growing population and aging society has resulted in a major unmet health need. CNS drug development has stagnated in some areas despite concerted effort over the past few decades.

Adobe Stock 340920311
Apr 12, 2023

How Predictive Drug Adherence Can Forecast Patient Dropout in Asthma Clinical Trials

Poor medication adherence has a significant impact on the viability of asthma clinical trials. Inhaled corticosteroids, for instance, have an adherence rate of ∼50%, according to a systematic review of 51 observational studies.